We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.23B
AUM Growth
-$1.54B
Cap. Flow
-$88.6M
Cap. Flow %
-1.08%
Top 10 Hldgs %
15.8%
Holding
2,674
New
67
Increased
207
Reduced
1,057
Closed
107

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 14.8%
3 Healthcare 13.78%
4 Industrials 9.72%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
2376
Sarepta Therapeutics
SRPT
$1.94B
$9.93K ﹤0.01%
91
+4
+5% +$500
JAZZ icon
2377
Jazz Pharmaceuticals
JAZZ
$16.2B
$9.92K ﹤0.01%
80
-1
-1% -$148
XPO icon
2378
XPO
XPO
$24.5B
$9.75K ﹤0.01%
494
-6
-1% -$166
ARMK icon
2379
Aramark
ARMK
$15.9B
$9.68K ﹤0.01%
463
-4
-0.9% -$104
HDS
2380
DELISTED
HD Supply Holdings, Inc.
HDS
$9.49K ﹤0.01%
253
-2
-0.8% -$77
VER
2381
DELISTED
VEREIT, Inc.
VER
$9.48K ﹤0.01%
265
-2
-0.7% -$74
GRUB
2382
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$9.45K ﹤0.01%
62
-1
-2% -$188
ON icon
2383
ON Semiconductor
ON
$32.4B
$9.41K ﹤0.01%
570
-14
-2% -$242
USFD icon
2384
US Foods
USFD
$24B
$9.3K ﹤0.01%
294
-3
-1% -$93
IONS icon
2385
Ionis Pharmaceuticals
IONS
$9.39B
$9.19K ﹤0.01%
170
-2
-1% -$102
TWLO icon
2386
Twilio
TWLO
$37.9B
$9.02K ﹤0.01%
101
+3
+3% +$244
GWRE icon
2387
Guidewire Software
GWRE
$14.4B
$8.91K ﹤0.01%
111
+1
+0.9% +$87
ALNY icon
2388
Alnylam Pharmaceuticals
ALNY
$30B
$8.89K ﹤0.01%
122
-1
-0.8% -$77
GLPI icon
2389
Gaming and Leisure Properties
GLPI
$12.5B
$8.88K ﹤0.01%
275
-3
-1% -$102
OPLN
2390
Openlane
OPLN
$4.34B
$8.78K ﹤0.01%
486
-3
-0.6% -$62
BKI
2391
DELISTED
Black Knight, Inc. Common Stock
BKI
$8.74K ﹤0.01%
194
-1
-0.5% -$47
HLF icon
2392
Herbalife
HLF
$1.23B
$8.72K ﹤0.01%
148
-1
-0.7% -$55
NBIX icon
2393
Neurocrine Biosciences
NBIX
$15.9B
$8.71K ﹤0.01%
122
-1
-0.8% -$96
BFAM icon
2394
Bright Horizons
BFAM
$3.76B
$8.69K ﹤0.01%
78
-1
-1% -$115
ATH
2395
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$8.64K ﹤0.01%
217
-2
-0.9% -$90
BAH icon
2396
Booz Allen Hamilton
BAH
$9.43B
$8.56K ﹤0.01%
190
-2
-1% -$98
BERY
2397
DELISTED
Berry Global Group, Inc.
BERY
$8.55K ﹤0.01%
196
-1
-0.5% -$43
VOYA icon
2398
Voya Financial
VOYA
$9.01B
$8.51K ﹤0.01%
212
-9
-4% -$400
SGEN
2399
DELISTED
Seagen Inc. Common Stock
SGEN
$8.39K ﹤0.01%
148
+1
+0.7% +$63
LSXMK
2400
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$8.36K ﹤0.01%
297
-6
-2% -$183

Similar funds

MetLife Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, MetLife Investment Management held 2,674 positions worth $8.23B, down 16% from $9.77B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q4 2018 filing shows 67 new, 207 increased, 1,057 reduced and 107 closed positions. Its largest new stake was Equitrans Midstream Corporation Common Stock: 124,047 shares worth $2.48M. The largest sale was Energy Transfer Partners, L.P., an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2018 buy was Equitrans Midstream Corporation Common Stock: 124,047 shares worth $2.48M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $57.5M increase.
  • MetLife Investment Management's biggest Q4 2018 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $12M.
  • MetLife Investment Management fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $28.9M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $8.23B portfolio in Q4 2018.
  • MetLife Investment Management opened 67 new positions and closed 107 in Q4 2018.
  • MetLife Investment Management's portfolio value fell 16% quarter-over-quarter to $8.23B.

Based on MetLife Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.